Ayman Rizkalla

Ayman Rizkalla

Ayman Rizkalla focuses his practice on white collar defense and government investigations related to healthcare fraud and financial crimes. Clients turn to him for strategic counsel on regulatory and compliance matters involving anti-corruption, False Claims Act, Foreign Corrupt Practices Act (FCPA), Racketeer Influenced and Corrupt Organizations Act (RICO), export control, and privacy. His clients include hospitals and corporate entities under investigation for Medicare fraud stemming from qui tam cases, and complex commercial disputes involving securities fraud and government investigations.

Subscribe to all posts by Ayman Rizkalla

Supreme Court Resolves Statute of Limitation Circuit Split in False Claims Act Cases

Last month, in a unanimous decision, the U.S. Supreme Court ruled that the analysis of the applicable statute of limitations under the False Claims Act (FCA) as set forth in 31 U.S.C. § 3731 is the same regardless of whether the government intervenes in the action or not.  While the decision is not likely to affect either the government … Continue Reading

Has the DOJ Signaled a More Critical Approach to FCA Cases?

Defendants have faced an ever increasing number of qui tam actions, yet the government has historically declined to seek dismissal of those actions where it declined to intervene. On January 10, 2018, the Director of the DOJ Civil Division Commercial Litigation Branch’s Fraud Section issued a memorandum to all DOJ attorneys, including AUSAs, advising them that when declining to intervene … Continue Reading

LexBlog